Evidence Hub

Effect of Dapoxetine on intravaginal ejaculatory latency time (IELT) in premature ejaculation: a systematic review

Syed Salman Shah, Syed Hamid Habib, Omar Malik, Muhammad Haris Burki, Eemaz Nathaniel

Journal of Rehman Medical Institute, 2021

Abstract

Introduction: The safety and efficacy of Dapoxetine for the treatment of premature ejaculation (PE) is still controversial. Thus, we decided to conduct a systemic review to determine the sufficiency of conclusions.Objective: To evaluate the efficacy and safety of Dapoxetine in the treatment of patients with premature ejaculation and assess the reliability of the findings.Materials & Methods: Four original articles were identified by a systematic search of MEDLINE Database. Those articles were included in the review with clear mention of PE and Dapoxetine in titles and abstracts.Results: The mean IELT score recorded at baseline of each study is much lower than recorded after treatment with Dapoxetine. The difference between baseline IELT and post treatment IELT is significant in all studies.Conclusion: The evidence suggests that Dapoxetine may be a safe and effective drug for patients with PE.

How strong is the evidence?

Evidence Hub reads this as a systematic review. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free